Oncology Could cancer be the next mRNA breakthrough? mRNA vaccines achieved their first success against COVID-19, but could a cancer target be next?
Oncology AI-derived cancer vaccines: the pharmaphorum podcast Today on the pharmaphorum podcast, Editor in Chief Jonah Comstock welcomes Hedi Ben Brahim and Eric Quéméneur, CEO and chief science off
Oncology Cancer vaccines: providing the edge in oncology In this article, Ben Hargreaves looks into the promise of cancer vaccines and how this treatment modality may offer advantages over existing immunotherapies in the oncology sector.
News Moderna and Merck expand partnership to develop new cancer v... Moderna and Merck & Co have expanded their partnership to develop and commercialise novel personalised messenger RNA (mRNA) cancer vaccines.
News Scancell to collaborate with charity CRUK on cancer vaccine Trial will combine cancer vaccine with checkpoint inhibitor
News Lilly joins cancer vaccine race with CureVac alliance Lilly has signed a deal with CureVac to develop up to five next-generation cancer vaccines which use messenger RNA (mRNA) technology.
News Rezzayo antifungal okayed as Candida auris rings alarm bells Drug is first new echinocandin to be approved for marketing in the US in more than a decade.
R&D Sponsored An inside guide to unlocking clinical research in the UK An inside guide to unlocking clinical research in the UK
